Quantbot Technologies LP Acquires Shares of 21,730 Agilent Technologies, Inc. $A

Quantbot Technologies LP bought a new position in Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 21,730 shares of the medical research company’s stock, valued at approximately $2,886,000.

Several other institutional investors also recently modified their holdings of the business. Fiduciary Trust Co increased its position in shares of Agilent Technologies by 1.6% during the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after acquiring an additional 77 shares during the last quarter. Sapient Capital LLC boosted its position in Agilent Technologies by 4.2% in the first quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after purchasing an additional 85 shares during the last quarter. Plan A Wealth LLC boosted its position in Agilent Technologies by 3.2% in the fourth quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after purchasing an additional 92 shares during the last quarter. UNIVEST FINANCIAL Corp grew its stake in Agilent Technologies by 1.3% in the 2nd quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock valued at $949,000 after purchasing an additional 93 shares during the period. Finally, IHT Wealth Management LLC increased its position in shares of Agilent Technologies by 4.9% during the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after purchasing an additional 96 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on A. Wells Fargo & Company cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Piper Sandler started coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective on the stock. TD Cowen boosted their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price for the company. Finally, HSBC lowered their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Trading Up 0.2%

Shares of Agilent Technologies stock opened at $159.25 on Monday. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $160.51. The stock’s 50-day simple moving average is $137.57 and its 200 day simple moving average is $126.17. The stock has a market capitalization of $44.98 billion, a P/E ratio of 31.98, a P/E/G ratio of 2.80 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.